Skip to content

Betamethasone Dipropionate

Betamethasone dipropionate (Lotrisone) is a topical corticosteroid that reduces inflammatory skin symptoms such as swelling, redness and itching. It appears in this catalogue as two combination products: Lotrisone and Wynzora.

Lotrisone

Tinea Cruris, Tinea Corporis, Tinea Pedis

10gr · 20gr

Clotrimazole and betamethasone cream for ringworm with itching and swelling. The antifungal kills the fungus while the steroid eases inflammation.

From$5.00/ tubeView

Wynzora

Plaque Psoriasis

15g

Calcipotriol and betamethasone dipropionate cream for plaque psoriasis. The calcipotriol slows skin cell growth, while the steroid reduces inflammation.

From$55.20/ tubeView

Key points

  • Every product in this catalogue pairs betamethasone dipropionate with a second active ingredient: clotrimazole in Lotrisone and calcipotriol in Wynzora.
  • Lotrisone is listed for fungal skin infections such as Tinea Cruris and Tinea Corporis, while Wynzora is listed for plaque psoriasis.
  • Absorption of a topical corticosteroid and the risk of adverse effects can increase with excessive or prolonged use.

Common questions about Betamethasone Dipropionate

What is the originator brand behind Lotrisone?

Lotrisone originates from Schering-Plough, while Wynzora is developed by MC2 Therapeutics.

Is betamethasone dipropionate ever listed on its own in this catalogue?

No. Every product here combines it with a second active ingredient (clotrimazole in Lotrisone or calcipotriol in Wynzora), and no single-ingredient formulation is attached.

Further reading